Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Average: 2021-2024

Historic Equity Average for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $4.6 million.

  • Biofrontera's Equity Average fell 144.09% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 144.09%. This contributed to the annual value of $4.6 million for FY2024, which is 67.82% down from last year.
  • Biofrontera's Equity Average amounted to $4.6 million in FY2024, which was down 67.82% from $14.3 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Equity Average ranged from a high of $17.6 million in FY2022 and a low of $4.6 million during FY2024.
  • Over the past 3 years, Biofrontera's median Equity Average value was $14.3 million (recorded in 2023), while the average stood at $12.2 million.
  • Per our database at Business Quant, Biofrontera's Equity Average soared by 105.15% in 2022 and then slumped by 67.82% in 2024.
  • Over the past 4 years, Biofrontera's Equity Average (Yearly) stood at $8.6 million in 2021, then spiked by 105.15% to $17.6 million in 2022, then declined by 18.59% to $14.3 million in 2023, then plummeted by 67.82% to $4.6 million in 2024.